查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2065234

醫療詐騙偵測市場預測至2034年－全球分析（按組件、解決方案類型、技術、詐騙類型、應用、最終用戶和地區分類）

Healthcare Fraud Detection Market Forecasts to 2034 - Global Analysis By Component (Software and Services), Solution Type, Technology, Fraud Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球醫療保健詐欺偵測市場規模將達到 54 億美元，到 2034 年將達到 147 億美元，預測期內複合年成長率為 13.3%。

醫療保健詐欺檢測涵蓋一系列軟體解決方案、分析平台和服務，旨在識別、預防和調查醫療保健支付和計費生態系統中的詐欺、浪費和濫用行為。這些系統利用人工智慧、機器學習、預測分析和自然語言處理等先進技術，分析大量的計費、發票、處方箋和資格數據，以偵測顯示存在詐欺行為的異常模式。

醫療詐騙造成的損失日益嚴重，以及為防止醫療詐欺而加強的監管要求。

醫療保健詐騙每年對全球公共和私人支付方造成數千億美元的損失，其形式多種多樣，包括虛假索賠、過度收​​費、處方藥挪用和身份盜竊等。美國、歐洲和其他地區的政府和監管機構正在採取應對措施，推出嚴格的法規，要求支付方必須具備主動詐騙偵測能力，才能參與相關專案。除了美國醫療保險和醫療補助服務中心 (CMS) 對醫療補助和醫療保險詐欺預防的要求外，各州保險法規也迫使私人保險公司投資於先進的人工智慧驅動型檢測平台，以識別傳統規則系統無法處理的複雜多方詐欺行為。

誤報率過高會阻礙合法帳單的處理。

醫療保健詐騙偵測系統面臨的一大挑戰是誤報率過高。這會導致合法索賠被錯誤地標記為需要調查，從而給支付方和醫療服務提供者都帶來行政負擔。高誤報率會削弱臨床醫生和管理人員對檢測系統的信任，可能導致自動化警報的採用率降低或繼續依賴人工審核流程。調整詐欺檢測演算法以達到適當的靈敏度，同時避免產生難以管理的待調查列表，需要大量的模型調優和專業知識。除了這些技術挑戰之外，詐欺手段的動態變化以及調查方法的不斷演變，也要求解決方案供應商持續投資於模型改進。

利用人工智慧和預測分析進行即時預付款詐欺預防

詐欺偵測正從付款後的審計和催收發展到付款前的即時預防，這代表著市場上最大的成長機會。人工智慧驅動的預測分析平台能夠基於從歷史詐欺模式中提取的複雜行為模型，在毫秒內評估索賠。這使得付款方能夠在付款前拒絕或標記可疑索賠，從而避免成本高昂且耗時的催收流程。網路分析功能的整合，能夠對醫療服務提供者、結算機構和患者之間的關係進行建模，從而識別有組織的詐欺團夥，進一步增強了預防能力。即時偵測能力正成為付款方尋求最大限度減少詐欺相關經濟損失的關鍵競爭優勢。

醫療詐騙手段日益複雜且不斷演變

醫療詐騙不斷調整作案手法，以應對檢測能力的提升，並開發新的調查方法，利用監管漏洞、數位身分安全漏洞以及新興的遠距遠端醫療計費框架。遠端醫療詐騙的興起，包括虛假遠距醫療和對未實際提供的服務進行不當收費，帶來了新的檢測挑戰，需要快速更新模型。此外，日益複雜的組織犯罪網路利用具備臨床知識的醫療專業人員來建立看似合法的欺詐性索賠，即使是基於規則的系統和基礎機器學習系統也難以應對。詐欺偵測領域的對抗性使得持續投資於自適應人工智慧系統和人工專家監督至關重要。

新型冠狀病毒（COVID-19）的影響：

新冠疫情導致醫療詐騙活動激增，緊急授權的新遠端醫療服務、擴大的計費代碼以及救助計畫提供的資金，都為濫用行為提供了滋生的溫床。針對新冠病毒檢測、治療和疫苗接種服務的欺詐性索賠給政府和私人保險公司造成了重大損失。這場危機促使保險公司意識到，傳統的基於規則的系統不足以大規模地檢測出各種新的欺詐手段，同時也加速了對人工智慧驅動的欺詐檢測能力的投資。疫情過後，不斷擴展的遠距遠端醫療計費體系和持續存在的詐欺模式，繼續推動對具備自適應檢測能力的高階詐欺分析平台的需求。

在預測期內，軟體領域預計將佔據最大的市場佔有率。

在預測期內，軟體領域預計將佔據最大的市場佔有率。進階分析軟體、人工智慧驅動的理賠審核平台和即時偵測引擎是詐欺偵測解決方案中最有價值的組成部分，能夠為健康保險公司、政府支付方和醫療服務提供者帶來可觀的授權和訂閱收入。向SaaS交付模式的轉變正在擴大軟體的普及範圍，使即使是小規模的地方支付方也能實施以前只有大型全國性保險公司才能使用的先進詐欺預防功能。演算法的持續改進以及與理賠管理系統的日益整合，正在支撐著對軟體領域的強勁需求。

預計人工智慧（AI）領域在預測期內將呈現最高的複合年成長率。

在預測期內，軟體領域預計將呈現最高的成長率。與傳統的基於規則的方法相比，人工智慧平台能夠識別大型多維資料集中人類分析師無法發現的細微而複雜的模式，從而提供更卓越的詐欺偵測準確率。將無監督學習應用於異常檢測、利用圖神經網路繪製詐欺網路以及利用自然語言處理分析非結構化保險索賠數據，都在擴展人工智慧的檢測能力，以應對日益多樣化的詐欺類型。此外，供應商對可解釋人工智慧的投入不斷增加，也有助於滿足監管機構對審計可讀詐欺偵測決策透明度的要求。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率。在美國，對詐欺偵測解決方案的絕對需求最高，這主要得益於其龐大的公共醫療保險計劃、大規模的私人保險市場，以及由司法部和監察長辦公室管理的嚴格的聯邦反詐欺執法框架。違反《虛假申報法》行為的巨額罰款，以及美國醫療保險和醫療補助服務中心（CMS）強調主動預防的「支付與追查」改革舉措，正迫使醫療機構投資於先進的詐欺分析平台。在加拿大，各省正在實施的醫療保健詐欺預防計畫的擴展，也推動了該地區市場規模的成長。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率。中國、印度、韓國以及東南亞各國快速擴張的國家醫療保險體系，加劇了醫療詐欺的風險，各國政府和保險監理機關也紛紛要求加大對詐欺防範的投資。該地區龐大且不斷發展的數位醫療生態系統，以及人工智慧在金融服務和政府運營中日益普及，為先進的醫療詐欺分析平台創造了技術友善的環境。新興亞洲市場私人保險公司對醫療詐騙風險的日益重視，也進一步推動了該地區的需求。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶的興趣，我們將提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章：全球醫療詐騙偵測市場：按組件分類

  • 軟體
  • 服務

第6章：全球醫療詐騙偵測市場：依解決方案類型分類

  • 支付安全解決方案
  • 保險理賠審核解決方案
  • 身分和存取管理解決方案
  • 收入週期監控解決方案
  • 審計和收款解決方案
  • 個案管理解決方案
  • 網路分析解決方案

第7章：全球醫療詐騙偵測市場：依技術分類

  • 人工智慧（AI）
  • 機器學習（ML）
  • 預測分析
  • 巨量資料分析
  • 區塊鏈
  • 機器人流程自動化 (RPA)
  • 自然語言處理（NLP）

第8章：全球醫療詐騙偵測市場：依詐欺類型分類

  • 保險索賠詐騙
  • 帳單詐騙
  • 處方箋詐欺
  • 身份盜竊和資格詐騙
  • 醫療保健提供者的詐欺行為
  • 查處浪費和欺詐行為

第9章：全球醫療詐騙偵測市場：按應用領域分類

  • 保險理賠分析
  • 付款的準確性和完整性
  • 對醫療保健提供者的監測
  • 用戶/病患分析
  • 藥局帳單監控
  • 合規與風險管理
  • 即時詐欺偵測

第10章：全球醫療詐騙偵測市場：依最終用戶分類

  • 公立和政府附屬醫療機構
  • 私人醫療保險提供者
  • 醫療保健支付方
  • 醫療服務提供方
  • 第三方管理協會 (TPA)
  • 藥品福利管理公司（PBM）

第11章：全球醫療詐騙偵測市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第12章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第13章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第14章：公司簡介

  • SAS Institute Inc.
  • IBM Corporation
  • Optum Inc.
  • Cotiviti
  • LexisNexis Risk Solutions
  • Conduent Inc.
  • EXL Service
  • Wipro Limited
  • HCL Technologies
  • Fair Isaac Corporation
  • PegaSystems Inc.
  • Oracle Corporation
  • McKesson Corporation
  • Gainwell Technologies
  • NTT DATA
Product Code: SMRC36785

According to Stratistics MRC, the Global Healthcare Fraud Detection Market is accounted for $5.4 billion in 2026 and is expected to reach $14.7 billion by 2034, growing at a CAGR of 13.3% during the forecast period. Healthcare Fraud Detection encompasses a broad set of software solutions, analytical platforms, and services that identify, prevent, and investigate fraudulent, wasteful, and abusive activities within healthcare payment and claims ecosystems. Utilizing advanced technologies including artificial intelligence, machine learning, predictive analytics, and natural language processing, these systems analyze vast volumes of claims, billing, prescription, and eligibility data to detect anomalous patterns indicative of fraud.

Market Dynamics:

Driver:

Escalating healthcare fraud losses and growing regulatory mandates for fraud prevention

Healthcare fraud imposes an estimated hundreds of billions of dollars in annual losses on public and private payers globally, with schemes ranging from phantom billing and upcoding to prescription drug diversion and identity theft. Governments and regulatory bodies in the United States, Europe, and beyond have responded with stringent mandates requiring payers to implement proactive fraud detection capabilities as a condition of program participation. CMS requirements for Medicaid and Medicare fraud prevention, combined with commercial insurer obligations under state insurance regulations, are compelling organizations to invest in sophisticated AI-driven detection platforms that can identify complex multi-party fraud schemes beyond the capability of traditional rule-based systems.

Restraint:

High false positive rates disrupting legitimate claims processing

A persistent challenge confronting healthcare fraud detection systems is the generation of excessive false positive alerts, which incorrectly flag legitimate claims for investigation and create administrative burden for payer organizations and healthcare providers alike. High false positive rates erode clinician and administrator trust in detection systems, potentially leading to reduced adoption of automated alerts and continued reliance on manual review processes. Calibrating fraud detection algorithms to achieve adequate sensitivity without generating unmanageable investigation queues requires extensive model tuning and domain expertise. This technical challenge, combined with the dynamic evolution of fraud schemes that continuously adapt to detection methodologies, demands ongoing model refinement investment from solution providers.

Opportunity:

AI and predictive analytics for real-time pre-payment fraud prevention

The evolution of fraud detection from post-payment audit and recovery to real-time pre-payment prevention represents the most significant growth opportunity in the market. AI-powered predictive analytics platforms can evaluate claims against complex behavioral models derived from historical fraud patterns in milliseconds, enabling payers to reject or flag suspicious claims before payment is disbursed, eliminating the costly and time-consuming process of recovery. The integration of network analytics capabilities, which model relationships between providers, billing entities, and patients to identify organized fraud rings, is further enhancing prevention efficacy. Real-time detection capabilities are becoming a competitive differentiator for payers seeking to minimize fraud-related financial losses.

Threat:

Sophisticated and continuously evolving healthcare fraud schemes

Healthcare fraudsters continuously adapt their schemes in response to advances in detection capabilities, developing new methodologies that exploit regulatory gaps, digital identity vulnerabilities, and emerging telehealth billing frameworks. The rise of telehealth fraud, involving fictitious remote consultations and improper billing for services never rendered, has created new detection challenges requiring rapid model updating. Additionally, increasingly sophisticated organized crime networks employing healthcare professionals with clinical knowledge to construct plausible fraudulent claims create challenges that rule-based and even basic machine learning systems struggle to address. The adversarial nature of the fraud detection domain necessitates continuous investment in adaptive AI systems and human expert oversight.

Covid-19 Impact:

The COVID-19 pandemic precipitated a surge in healthcare fraud activity, as emergency authorization of new telehealth services, expanded billing codes, and relief program funding created fertile ground for exploitation. Fraudulent billing for COVID-19 testing, treatment, and vaccination services generated significant losses across government and commercial payer programs. The crisis simultaneously accelerated investment in AI-driven fraud detection capabilities as payers recognized the inadequacy of legacy rule-based systems in detecting novel scheme variations at scale. Post-pandemic, the expanded telehealth billing ecosystem and residual fraud patterns have maintained heightened demand for advanced fraud analytics platforms with adaptive detection capabilities.

The Software segment is expected to be the largest during the forecast period

The Software segment is expected to account for the largest market share during the forecast period. Advanced analytics software, AI-driven claims review platforms, and real-time detection engines represent the highest-value components of fraud detection solutions, generating substantial licensing and subscription revenues from health insurers, government payers, and healthcare providers. The transition toward SaaS delivery models is broadening software accessibility and enabling smaller regional payers to deploy sophisticated fraud prevention capabilities previously available only to large national insurers. Continuous algorithmic enhancements and expanding integration with claims management systems sustain strong software segment demand.

The Artificial Intelligence (AI) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Software segment is predicted to witness the highest growth rate. AI-powered platforms demonstrate superior fraud detection accuracy compared to conventional rule-based approaches by identifying subtle and complex patterns across large, multidimensional datasets that are imperceptible to human analysts. The application of unsupervised learning for anomaly detection, graph neural networks for fraud network mapping, and natural language processing for unstructured claims data analysis is expanding AI's detection capabilities across an increasingly diverse range of fraud scheme types. Growing vendor investment in explainable AI is also addressing regulatory requirements for audit-ready fraud detection decision transparency.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. The United States generates the greatest absolute demand for fraud detection solutions, driven by the scale of its public healthcare programs, a large private insurance market, and stringent federal anti-fraud enforcement frameworks administered by the Department of Justice and Office of Inspector General. Significant financial penalties associated with False Claims Act violations, combined with CMS pay-and-chase reform initiatives emphasizing predictive prevention, are compelling healthcare organizations to invest in sophisticated fraud analytics platforms. Canada's evolving provincial healthcare fraud prevention programs contribute to regional market volume.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. Rapidly expanding national health insurance programs across China, India, South Korea, and Southeast Asia are generating growing exposure to fraudulent claims activity, prompting governments and insurance regulators to mandate fraud prevention investments. The region's large and growing digital health ecosystem, combined with increasing adoption of AI across financial services and government operations, is creating a technology-receptive environment for advanced healthcare fraud analytics platforms. Growing awareness of healthcare fraud risks among private insurers in emerging Asian markets is further fueling regional demand.

Key players in the market

Some of the key players in Global Healthcare Fraud Detection Market include SAS Institute Inc., IBM Corporation, Optum Inc., Cotiviti, LexisNexis Risk Solutions, Conduent Inc., EXL Service, Wipro Limited, HCL Technologies, Fair Isaac Corporation, PegaSystems Inc., Oracle Corporation, McKesson Corporation, Gainwell Technologies, and NTT DATA.

Key Developments:

In January 2026, Cotiviti announced the launch of its enhanced Eliza Payment Integrity platform, incorporating new generative AI capabilities for automated explanation of benefits review and anomaly investigation narrative generation. The upgraded platform enables payer organizations to significantly accelerate their claims review workflows by automating the identification and documentation of overpayment opportunities across complex multi-code billing scenarios, reducing manual analyst workload.

In March 2026, IBM Corporation announced a strategic partnership with a major U.S. government health program administrator to deploy its Watson Health fraud analytics platform across a portfolio of Medicaid managed care plans. The engagement focuses on implementing real-time pre-payment fraud screening using advanced network analytics to identify provider fraud rings and coordinated billing anomalies, targeting a measurable reduction in improper payment rates within the first year of deployment.

Components Covered:

  • Software
  • Services

Solution Types Covered:

  • Payment Integrity Solutions
  • Claims Review Solutions
  • Identity & Access Management Solutions
  • Revenue Cycle Monitoring Solutions
  • Audit & Recovery Solutions
  • Case Management Solutions
  • Network Analytics Solutions

Technologies Covered:

  • Artificial Intelligence (AI)
  • Machine Learning (ML)
  • Predictive Analytics
  • Big Data Analytics
  • Blockchain
  • Robotic Process Automation (RPA)
  • Natural Language Processing (NLP)

Fraud Types Covered:

  • Claims Fraud
  • Billing Fraud
  • Prescription Fraud
  • Identity Theft & Eligibility Fraud
  • Provider Fraud
  • Waste & Abuse Detection

Applications Covered:

  • Insurance Claims Analysis
  • Payment Accuracy & Integrity
  • Provider Monitoring
  • Member & Patient Analytics
  • Pharmacy Claims Monitoring
  • Compliance & Risk Management
  • Real-Time Fraud Detection

End Users Covered:

  • Public & Government Healthcare Agencies
  • Private Health Insurance Providers
  • Healthcare Payers
  • Healthcare Providers
  • Third-Party Administrators (TPAs)
  • Pharmacy Benefit Managers (PBMs)

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Healthcare Fraud Detection Market, By Component

  • 5.1 Software
  • 5.2 Services

6 Global Healthcare Fraud Detection Market, By Solution Type

  • 6.1 Payment Integrity Solutions
  • 6.2 Claims Review Solutions
  • 6.3 Identity & Access Management Solutions
  • 6.4 Revenue Cycle Monitoring Solutions
  • 6.5 Audit & Recovery Solutions
  • 6.6 Case Management Solutions
  • 6.7 Network Analytics Solutions

7 Global Healthcare Fraud Detection Market, By Technology

  • 7.1 Artificial Intelligence (AI)
  • 7.2 Machine Learning (ML)
  • 7.3 Predictive Analytics
  • 7.4 Big Data Analytics
  • 7.5 Blockchain
  • 7.6 Robotic Process Automation (RPA)
  • 7.7 Natural Language Processing (NLP)

8 Global Healthcare Fraud Detection Market, By Fraud Type

  • 8.1 Claims Fraud
  • 8.2 Billing Fraud
  • 8.3 Prescription Fraud
  • 8.4 Identity Theft & Eligibility Fraud
  • 8.5 Provider Fraud
  • 8.6 Waste & Abuse Detection

9 Global Healthcare Fraud Detection Market, By Application

  • 9.1 Insurance Claims Analysis
  • 9.2 Payment Accuracy & Integrity
  • 9.3 Provider Monitoring
  • 9.4 Member & Patient Analytics
  • 9.5 Pharmacy Claims Monitoring
  • 9.6 Compliance & Risk Management
  • 9.7 Real-Time Fraud Detection

10 Global Healthcare Fraud Detection Market, By End User

  • 10.1 Public & Government Healthcare Agencies
  • 10.2 Private Health Insurance Providers
  • 10.3 Healthcare Payers
  • 10.4 Healthcare Providers
  • 10.5 Third-Party Administrators (TPAs)
  • 10.6 Pharmacy Benefit Managers (PBMs)

11 Global Healthcare Fraud Detection Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 SAS Institute Inc.
  • 14.2 IBM Corporation
  • 14.3 Optum Inc.
  • 14.4 Cotiviti
  • 14.5 LexisNexis Risk Solutions
  • 14.6 Conduent Inc.
  • 14.7 EXL Service
  • 14.8 Wipro Limited
  • 14.9 HCL Technologies
  • 14.10 Fair Isaac Corporation
  • 14.11 PegaSystems Inc.
  • 14.12 Oracle Corporation
  • 14.13 McKesson Corporation
  • 14.14 Gainwell Technologies
  • 14.15 NTT DATA

List of Tables

  • Table 1 Global Healthcare Fraud Detection Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Healthcare Fraud Detection Market Outlook, By Component (2023-2034) ($MN)
  • Table 3 Global Healthcare Fraud Detection Market Outlook, By Software (2023-2034) ($MN)
  • Table 4 Global Healthcare Fraud Detection Market Outlook, By Services (2023-2034) ($MN)
  • Table 5 Global Healthcare Fraud Detection Market Outlook, By Solution Type (2023-2034) ($MN)
  • Table 6 Global Healthcare Fraud Detection Market Outlook, By Payment Integrity Solutions (2023-2034) ($MN)
  • Table 7 Global Healthcare Fraud Detection Market Outlook, By Claims Review Solutions (2023-2034) ($MN)
  • Table 8 Global Healthcare Fraud Detection Market Outlook, By Identity & Access Management Solutions (2023-2034) ($MN)
  • Table 9 Global Healthcare Fraud Detection Market Outlook, By Revenue Cycle Monitoring Solutions (2023-2034) ($MN)
  • Table 10 Global Healthcare Fraud Detection Market Outlook, By Audit & Recovery Solutions (2023-2034) ($MN)
  • Table 11 Global Healthcare Fraud Detection Market Outlook, By Case Management Solutions (2023-2034) ($MN)
  • Table 12 Global Healthcare Fraud Detection Market Outlook, By Network Analytics Solutions (2023-2034) ($MN)
  • Table 13 Global Healthcare Fraud Detection Market Outlook, By Technology (2023-2034) ($MN)
  • Table 14 Global Healthcare Fraud Detection Market Outlook, By Artificial Intelligence (AI) (2023-2034) ($MN)
  • Table 15 Global Healthcare Fraud Detection Market Outlook, By Machine Learning (ML) (2023-2034) ($MN)
  • Table 16 Global Healthcare Fraud Detection Market Outlook, By Predictive Analytics (2023-2034) ($MN)
  • Table 17 Global Healthcare Fraud Detection Market Outlook, By Big Data Analytics (2023-2034) ($MN)
  • Table 18 Global Healthcare Fraud Detection Market Outlook, By Blockchain (2023-2034) ($MN)
  • Table 19 Global Healthcare Fraud Detection Market Outlook, By Robotic Process Automation (RPA) (2023-2034) ($MN)
  • Table 20 Global Healthcare Fraud Detection Market Outlook, By Natural Language Processing (NLP) (2023-2034) ($MN)
  • Table 21 Global Healthcare Fraud Detection Market Outlook, By Fraud Type (2023-2034) ($MN)
  • Table 22 Global Healthcare Fraud Detection Market Outlook, By Claims Fraud (2023-2034) ($MN)
  • Table 23 Global Healthcare Fraud Detection Market Outlook, By Billing Fraud (2023-2034) ($MN)
  • Table 24 Global Healthcare Fraud Detection Market Outlook, By Prescription Fraud (2023-2034) ($MN)
  • Table 25 Global Healthcare Fraud Detection Market Outlook, By Identity Theft & Eligibility Fraud (2023-2034) ($MN)
  • Table 26 Global Healthcare Fraud Detection Market Outlook, By Provider Fraud (2023-2034) ($MN)
  • Table 27 Global Healthcare Fraud Detection Market Outlook, By Waste & Abuse Detection (2023-2034) ($MN)
  • Table 28 Global Healthcare Fraud Detection Market Outlook, By Application (2023-2034) ($MN)
  • Table 29 Global Healthcare Fraud Detection Market Outlook, By Insurance Claims Analysis (2023-2034) ($MN)
  • Table 30 Global Healthcare Fraud Detection Market Outlook, By Payment Accuracy & Integrity (2023-2034) ($MN)
  • Table 31 Global Healthcare Fraud Detection Market Outlook, By Provider Monitoring (2023-2034) ($MN)
  • Table 32 Global Healthcare Fraud Detection Market Outlook, By Member & Patient Analytics (2023-2034) ($MN)
  • Table 33 Global Healthcare Fraud Detection Market Outlook, By Pharmacy Claims Monitoring (2023-2034) ($MN)
  • Table 34 Global Healthcare Fraud Detection Market Outlook, By Compliance & Risk Management (2023-2034) ($MN)
  • Table 35 Global Healthcare Fraud Detection Market Outlook, By Real-Time Fraud Detection (2023-2034) ($MN)
  • Table 36 Global Healthcare Fraud Detection Market Outlook, By End User (2023-2034) ($MN)
  • Table 37 Global Healthcare Fraud Detection Market Outlook, By Public & Government Healthcare Agencies (2023-2034) ($MN)
  • Table 38 Global Healthcare Fraud Detection Market Outlook, By Private Health Insurance Providers (2023-2034) ($MN)
  • Table 39 Global Healthcare Fraud Detection Market Outlook, By Healthcare Payers (2023-2034) ($MN)
  • Table 40 Global Healthcare Fraud Detection Market Outlook, By Healthcare Providers (2023-2034) ($MN)
  • Table 41 Global Healthcare Fraud Detection Market Outlook, By Third-Party Administrators (TPAs) (2023-2034) ($MN)
  • Table 42 Global Healthcare Fraud Detection Market Outlook, By Pharmacy Benefit Managers (PBMs) (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.